Moreover, the KOR agonist (as well as DOR and MOR partial agonist) Nalbuphine (3 and 10 mg/kg; s.c.)prevented TAT-HIV-1 (0.3 mg/kg)-induced itch in C57BL/6J mice. This evidence concerns the gene OPRM1 and Pruritus.